Abstracts on this page have been chosen andedited by Dr Trevor Watts
Abstract
There was no recurrence in a 1–6 year follow-up of 8 aggressive lesions.
Main
Kaban LB, Troulis MJ et al. J Oral Maxillofac Surg 2002; 60: 1103–1111
Giant cell tumours rarely metastasize, but frequently recur with reported rates as high as 70%, and may be locally aggressive. There currently is considerable interest in the role of angiogenesis in tumour spread, and the authors postulated that giant cell lesions might depend on this mechanism for some of their effects.
This study involved 6 patients who had already experienced 8 recurrences, and 2 who had large, rapidly growing lesions. Following enucleation of the lesions with preservation of teeth and nerves, a course of interferon alpha was given daily for 6 to 8 months.
There were several complications which the authors viewed as minor, and all patients completed scheduled treatment. Mean duration of follow-up was 2 yrs (range 05–67 yrs), and 7 patients had completed treatment. There were no fractures, infections or recurrences, and in all cases the bone cavity rapidly filled with bone.
Rights and permissions
About this article
Cite this article
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. Br Dent J 194, 555 (2003). https://doi.org/10.1038/sj.bdj.4810200
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.4810200